Tag: RMAT
FDA Grants RMAT To ExCellThera’s Cell Expansion Technology
ExCellThera Inc., an advanced clinical stage biotechnology
company delivering molecules and bioengineering solutions to expand stem and
immune cells for therapeutic use, has announced that the U.S. Food and Drug
Administration (FDA) has granted regenerative medicine advanced therapy (RMAT)
designation to its lead...
AmnioFix® Injectable Granted RMAT Designation By The FDA For The Treatment Of Osteoarthritis Of...
MiMedx Group, Inc. developed the proprietary PURION® Process that separates placental tissues collected after birth, cleans and reassembles layers, and then dehydrates the tissue for long term storage under sterile conditions. The PURION® Process removes free blood while retaining...
